Ignite Creation Date:
2024-05-06 @ 1:34 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04067115
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-21
First Post:
2019-08-21
Brief Title:
SARC037 A Phase III Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
Sponsor:
Sarcoma Alliance for Research through Collaboration
Organization:
Sarcoma Alliance for Research through Collaboration
Organization Data
Organization:
Sarcoma Alliance for Research through Collaboration
Class:
OTHER
Study ID:
SARC037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sarcoma Alliance for Research through Collaboration
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen Scientific Affairs LLC | INDUSTRY |
| National Institutes of Health NIH | NIH |
| National Cancer Institute NCI | NIH |